Epstein–Barr Virus Lacking Glycoprotein gp85 Cannot Infect B Cells and Epithelial Cells
- 1 October 2000
- Vol. 276 (1) , 52-58
- https://doi.org/10.1006/viro.2000.0531
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Princess Takamatsu Cancer Research Fund
This publication has 20 references indexed in Scilit:
- Persistent Epstein-Barr virus infection in a human T-cell line: unique program of latent virus expression.The EMBO Journal, 1995
- Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBVJournal of Virology, 1994
- Epstein-Barr Virus Glycoprotein gp85 Associates with the BKRF2 Gene Product and Is Incompletely Processed as a Recombinant ProteinVirology, 1993
- Characteristics of three human gastric cancer cell lines, NU-GC-2, NU-GC-3 and NU-GC-4Surgery Today, 1988
- Identification of the Epstein-Barr virus gp85 geneJournal of Virology, 1988
- Epstein-barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosisCell, 1987
- Two major outer envelope glycoproteins of Epstein-Barr virus are encoded by the same geneJournal of Virology, 1985
- Cross‐linking of cell surface immunoglobulins induces epstein‐barr virus in burkitt lymphoma linesInternational Journal of Cancer, 1984
- Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity.Proceedings of the National Academy of Sciences, 1980
- Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virusJournal of Virology, 1976